| Autor: |
Safi S; Division of Thoracic Surgery, School of Medicine, University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany., Zimmermann GS; Department of Internal Medicine I, School of Medicine, University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany. |
| Jazyk: |
angličtina |
| Zdroj: |
Translational lung cancer research [Transl Lung Cancer Res] 2022 Jan; Vol. 11 (1), pp. 1-3. |
| DOI: |
10.21037/tlcr-21-972 |
| Abstrakt: |
Competing Interests: Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-21-972/coif). SS reports grants or contracts from Else Kröner Fresenius Stiftung, and payment or honoraria from Coliquio. GSZ reports grants or contracts from AstraZeneca, and payment or honoraria Roche, AstraZeneca, GSK, Pfizer, Boehringer Ingelheim, and Novartis. All payments were approved by the Klinikum rechts der Isar, Technical University of Munich. The authors have no other conflicts of interest to declare. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
